Article citationsMore>>

Cranney, A.N.N., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., et al. (2002) II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women. Endocrine Reviews, 23, 508-516.
https://doi.org/10.1210/er.2001-2002

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.